ARTICLE | Clinical News
2-methoxyestradiol: Phase I started
April 3, 2006 7:00 AM UTC
PRP began a double-blind, placebo-controlled U.S. Phase I trial in 50 healthy volunteers to evaluate subcutaneous doses of sustained-release injectable formulation of PulmoLAR. ...